Procurement of the drug OLIPUDASE ALFA 20 MG POWDER FOR SOL INJ FR IV
About This Opportunity
TranslatedThis tender concerns the procurement of a specific pharmaceutical product: OLIPUDASE ALFA 20 MG POWDER FOR SOLUTION FOR INJECTION, presented in a vial (FR IV). The description indicates a need for the acquisition of this medication, which is typically used for treating certain rare genetic disorders. While the description is concise, it clearly defines the item required. Further details regarding the quantity, specific formulation requirements, packaging standards, delivery timelines, and the contracting authority would typically be found in the full tender documentation. This procurement falls within the healthcare sector, specifically focusing on specialized pharmaceuticals. Bidders are expected to be suppliers or manufacturers capable of providing this drug, adhering to all relevant regulatory and quality standards for pharmaceutical products. The tender likely requires proof of authorization to distribute such medications and compliance with Good Distribution Practices (GDP). Interested parties should review the complete tender package for detailed specifications, eligibility criteria, submission procedures, and evaluation methodologies. The objective is to secure a reliable supply of OLIPUDASE ALFA to meet patient needs within the designated healthcare system.
This is a supplies contract in the health and medical services, transport and logistics and trade and industry sectors, with a focus on Pharmaceuticals, Warehousing, Logistics and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1.2 million.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, originating from Portugal and managed through the national public procurement portal, BASE, concerns the acquisition of a specific pharmaceutical product. The contracting authority is seeking to procure OLIPUDASE ALFA, presented as a 20 MG powder for solution for injection in a vial, intended for intravenous administration.
This procurement falls under the category of medical supplies, specifically focusing on specialized pharmaceutical products for patient treatment.
Typical requirements for such tenders include adherence to stringent quality standards and regulatory compliance, ensuring the product meets all necessary pharmacopoeia and national health authority specifications. Bidders will likely be required to demonstrate their capacity to supply the specified medication reliably and in the quantities requested. Furthermore, proposals often need to detail the origin of the active pharmaceutical ingredient, manufacturing processes, and relevant certifications. Packaging and labeling must comply with European Union regulations and be suitable for the storage and transport of sensitive medicinal products. Experience in supplying similar high-value or specialized pharmaceuticals to public health entities may also be a significant consideration.
The successful bidder will be expected to provide comprehensive documentation, including product information leaflets and any required import or distribution licenses.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 5, 2026. Last refreshed 5 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de São João E.P.E.
Unidade Local de Saúde de São João E.P.E. has issued 408 procurement notices on BidsFactory, including 0 currently open and 390 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €1,200,615. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to SANOFI - AVENTIS - PRODUTOS FARMACÊUTICOS, S. A.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de São João E.P.E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.